117 related articles for article (PubMed ID: 35007461)
1. Conditional cancer-specific survival after radical hepatectomy in patients with nonmetastatic intrahepatic cholangiocarcinoma.
Yan X; Wang L; Meng Z
Scand J Gastroenterol; 2022 Apr; 57(4):481-485. PubMed ID: 35007461
[TBL] [Abstract][Full Text] [Related]
2. How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.
Palumbo C; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Antonelli A; Karakiewicz PI
Urol Oncol; 2019 Dec; 37(12):893-899. PubMed ID: 31296422
[TBL] [Abstract][Full Text] [Related]
3. Conditional Survival of Patients With Nonmetastatic Renal Cell Carcinoma: How Cancer-Specific Mortality Changes After Nephrectomy.
Palumbo C; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Antonelli A; Karakiewicz PI
J Natl Compr Canc Netw; 2020 Jan; 18(1):44-51. PubMed ID: 31910387
[TBL] [Abstract][Full Text] [Related]
4. Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients.
Spolverato G; Kim Y; Ejaz A; Alexandrescu S; Marques H; Aldrighetti L; Gamblin TC; Pulitano C; Bauer TW; Shen F; Sandroussi C; Poultsides G; Maithel SK; Pawlik TM
JAMA Surg; 2015 Jun; 150(6):538-45. PubMed ID: 25831462
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?
Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD
Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704
[TBL] [Abstract][Full Text] [Related]
6. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
[TBL] [Abstract][Full Text] [Related]
7. Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience.
Ali SM; Clark CJ; Mounajjed T; Wu TT; Harmsen WS; Reid-Lombardo KM; Truty MJ; Kendrick ML; Farnell MB; Nagorney DM; Que FG
HPB (Oxford); 2015 Mar; 17(3):244-50. PubMed ID: 25410716
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.
Bagante F; Spolverato G; Merath K; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Endo I; Pawlik TM
Surgery; 2019 Dec; 166(6):983-990. PubMed ID: 31326191
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of prognostic factors influencing the outcome of intrahepatic cholangiocarcinoma].
Zhang L; Cai JQ; Bi XY; Zhao JJ; Xing GS; Yan T; Fu YX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):845-8. PubMed ID: 20137350
[TBL] [Abstract][Full Text] [Related]
10. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.
Clark CJ; Wood-Wentz CM; Reid-Lombardo KM; Kendrick ML; Huebner M; Que FG
HPB (Oxford); 2011 Sep; 13(9):612-20. PubMed ID: 21843261
[TBL] [Abstract][Full Text] [Related]
11. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic cholangiocarcinoma in Thailand.
Uttaravichien T; Bhudhisawasdi V; Pairojkul C; Pugkhem A
J Hepatobiliary Pancreat Surg; 1999; 6(2):128-35. PubMed ID: 10398899
[TBL] [Abstract][Full Text] [Related]
13. [Prognosis of 84 intrahepatic cholangiocarcinoma patients].
Li FH; Chen XQ; Luo HY; Li YH; Wang F; Qiu MZ; Teng KY; Li ZH; Xu RH
Ai Zheng; 2009 May; 28(5):528-32. PubMed ID: 19624884
[TBL] [Abstract][Full Text] [Related]
14. Indications for extended hepatectomy in the management of stage IV hilar cholangiocarcinoma.
Uchiyama K; Nakai T; Tani M; Onishi H; Kinoshita H; Kawai M; Ueno M; Yamaue H
Arch Surg; 2003 Sep; 138(9):1012-6. PubMed ID: 12963661
[TBL] [Abstract][Full Text] [Related]
15. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
16. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE
J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma.
Tokuda K; Morine Y; Saito Y; Yamada S; Miyazaki K; Yamashita S; Okikawa S; Ikemoto T; Imura S; Shimada M
Int J Clin Oncol; 2020 Dec; 25(12):2083-2089. PubMed ID: 32869120
[TBL] [Abstract][Full Text] [Related]
18. Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
Chiu TJ; Chen YJ; Kuo FY; Chen YY
PLoS One; 2020; 15(12):e0240791. PubMed ID: 33306714
[TBL] [Abstract][Full Text] [Related]
19. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
[TBL] [Abstract][Full Text] [Related]
20. The current management of hilar cholangiocarcinoma.
Jarnagin WR; Fong Y; Blumgart LH
Adv Surg; 1999; 33():345-73. PubMed ID: 10572576
[No Abstract] [Full Text] [Related]
[Next] [New Search]
